78
12
Growth Score
-9 pts
Heat Score
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
2366108
CIMERLI is an interchangeable ranibizumab biosimilar vascular endothelial inhibitor indicated for the treatment of retinal diseases.
About the Company
CIMERLI is an FDA-approved interchangeable ranibizumab biosimilar vascular endothelial growth inhibitor that is indicated for the treatment of multiple retinal diseases.
